Loruhama Delgado-Rivera Selected Research

Estradiol (Delestrogen)

1/2016

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Loruhama Delgado-Rivera Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2016
2	Neoplasms (Cancer) 01/2017 - 01/2016
1	Rheumatoid Arthritis 12/2017
1	Hypertension (High Blood Pressure) 12/2017
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2017

Drug/Important Bio-Agent (IBA)

1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017
1	FumaratesIBA 01/2017
1	ProdrugsIBA 01/2017
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017
1	Estrogen ReceptorsIBA 01/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	Tamoxifen FDA LinkGeneric 01/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2016
1	benzothiopheneIBA 01/2016

Therapy/Procedure

2	Therapeutics 01/2017 - 01/2016
1	Chemoprevention 01/2017